+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2025-2030- Product Image
Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2025-2030- Product Image
Sale

Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6146107
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Colloidal gold immunochromatographic assays are rapidly redefining point-of-care diagnostics, addressing the demand for accessible, efficient, and accurate testing solutions across diverse healthcare settings. This market demonstrates agility in adapting to decentralized care models and continues to see investment in next-generation technologies that drive operational resilience and strategic growth.

Market Snapshot: Colloidal Gold Immunochromatographic Assay Sector

The global colloidal gold immunochromatographic assay market is experiencing robust expansion, supported by a shift toward decentralized healthcare delivery and steady advancements in portable diagnostic platforms. Innovations in nanoparticle engineering and reader integration have extended assay usability to frontline clinicians, emergency responders, and consumers. The combination of rapid result delivery, cost-effectiveness, and ease of use positions colloidal gold assays as essential solutions amid evolving healthcare infrastructure.

Scope & Segmentation

This comprehensive report examines the full landscape of the colloidal gold immunochromatographic assay industry, spanning product innovations, market drivers, and evolving end-user needs. The analysis covers detailed market segmentation to deliver actionable insights for strategic decisions:

  • Application Areas: Cardiac markers (BNP/NT-proBNP, CK-MB, myoglobin, troponin I/T); drug abuse (amphetamines, cannabinoids, cocaine, opiates); infectious disease (COVID-19, hepatitis, HIV, influenza, malaria); pregnancy & fertility tests; tumor markers (AFP, CA125, CA19-9, CEA, PSA).
  • Product Formats: Cards optimized for high-throughput analysis; cassettes designed for balance between usability and robust results; strips for portability and field-based testing.
  • End-User Settings: Home care, hospital laboratories, point-of-care centers, and reference laboratories.
  • Technology Platforms: Colorimetric immunoassays, fluorescent immunoassays for quantitative results, lateral flow assays as the core foundation, and multiplex assay capabilities for multi-analyte testing.
  • Sample Types: Saliva, serum and plasma, urine, and whole blood.
  • Regional Coverage: Americas (including major U.S. states, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, and others); Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asian markets).
  • Key Industry Participants: Abbott Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Quidel Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, PerkinElmer, OraSure Technologies, Meridian Bioscience, and Danaher Corporation.

Key Takeaways for Senior Decision-Makers

  • Colloidal gold immunochromatographic assay diagnostics are bridging the gap between laboratory-grade accuracy and field-ready usability, providing near real-time insights in decentralized settings.
  • The market benefits from advances in conjugation chemistry, membrane materials, and digital integration, enabling advanced multiplexing and streamlined data connectivity for stakeholders.
  • Ecosystem-wide business model changes are increasing: companies are shifting from single-sale products toward subscription-based reader services and digital health partnerships.
  • Increasing regionalization and local manufacturing strategies are being adopted to address escalating supply chain pressures and regulatory variability, particularly in response to tariff influences.
  • Robust segmentation by application, technology, and sample type allows organizations to tailor product development to local clinical and regulatory requirements while building resilience across market cycles.
  • The sector exhibits a trend toward integrated diagnostics, where technological alliances and contract manufacturing support rapid scalability and competitive differentiation.

Tariff Impact: Navigating the 2025 U.S. Regulatory Shift

New tariffs introduced in the United States for 2025 have increased production and sourcing costs for gold nanoparticles and core assay components. These changes have elongated supply chains and intensified cost volatility, prompting manufacturers and distributors to diversify suppliers and reevaluate vendor agreements. Strategic responses include localized production, adoption of lean inventory management, and stronger advocacy efforts with regulatory bodies to uphold access during public health emergencies. Industry partnerships for domestic manufacturing are helping to mitigate ongoing risks.

Methodology & Data Sources

This research utilizes a rigorous approach combining quantitative and qualitative analysis. The study integrates secondary data from peer-reviewed journals, regulatory documents, and patent reviews, together with primary insights from industry leaders and technical experts. Data triangulation ensures accuracy and cross-verification of segmentation, application, and regional trends.

Why This Report Matters

  • Enables strategic planning by delivering a granular view of growth drivers, competitive strategies, and evolving business models in the colloidal gold immunochromatographic assay market.
  • Supports informed decisions on product development, market entry, and supply chain optimization through detailed technology and regional segmentation.
  • Equips decision-makers to proactively address regulatory changes and capitalize on demand shifts resulting from global healthcare trends.

Conclusion

Colloidal gold immunochromatographic assays are central to the evolution of point-of-care diagnostics. Continued innovation, digital integration, and supply chain agility position stakeholders to leverage future opportunities and navigate dynamic market conditions effectively.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing integration of smartphone connectivity for real-time data reporting in colloidal gold POCT
5.2. Development of multiplex colloidal gold assays enabling simultaneous detection of multiple biomarkers
5.3. Advancements in quantitative optical reader devices improving sensitivity and accuracy of gold immunochromatographic tests
5.4. Rising adoption of home-based colloidal gold rapid tests for respiratory infection and COVID-19 screening
5.5. Emergence of ecofriendly biosensor materials reducing reagent waste and environmental impact in POCT devices
5.6. Regulatory harmonization efforts accelerating global approval of colloidal gold immunoassays for infectious disease testing
5.7. Integration of artificial intelligence algorithms for enhanced interpretation of faint colloidal gold test lines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Colloidal Gold Immunochromatographic Assay POCT Market, by Application
8.1. Introduction
8.2. Cardiac Markers
8.2.1. BNP/NT-proBNP
8.2.2. CK-MB
8.2.3. Myoglobin
8.2.4. Troponin I/T
8.3. Drug Abuse
8.3.1. Amphetamines
8.3.2. Cannabinoids
8.3.3. Cocaine
8.3.4. Opiates
8.4. Infectious Disease
8.4.1. COVID-19
8.4.2. Hepatitis
8.4.3. HIV
8.4.4. Influenza
8.4.5. Malaria
8.5. Pregnancy & Fertility
8.5.1. Fertility Test
8.5.2. Pregnancy Test
8.6. Tumor Markers
8.6.1. AFP
8.6.2. CA125
8.6.3. CA19-9
8.6.4. CEA
8.6.5. PSA
9. Colloidal Gold Immunochromatographic Assay POCT Market, by Product
9.1. Introduction
9.2. Card
9.3. Cassette
9.4. Strip
10. Colloidal Gold Immunochromatographic Assay POCT Market, by End-User
10.1. Introduction
10.2. Home Care Settings
10.3. Hospital Laboratory
10.4. Point Of Care Centers
10.5. Reference Laboratories
11. Colloidal Gold Immunochromatographic Assay POCT Market, by Technology
11.1. Introduction
11.2. Colorimetric Immunoassay
11.3. Fluorescent Immunoassay
11.4. Lateral Flow Assay
11.5. Multiplex Assay
12. Colloidal Gold Immunochromatographic Assay POCT Market, by Sample Type
12.1. Introduction
12.2. Saliva
12.3. Serum And Plasma
12.4. Urine
12.5. Whole Blood
13. Americas Colloidal Gold Immunochromatographic Assay POCT Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Colloidal Gold Immunochromatographic Assay POCT Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. F. Hoffmann-La Roche AG
16.3.3. Becton, Dickinson and Company
16.3.4. Quidel Corporation
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. bioMérieux SA
16.3.7. PerkinElmer, Inc.
16.3.8. OraSure Technologies, Inc.
16.3.9. Meridian Bioscience, Inc.
16.3.10. Danaher Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET: RESEARCHAI
FIGURE 26. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET: RESEARCHSTATISTICS
FIGURE 27. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET: RESEARCHCONTACTS
FIGURE 28. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY BNP/NT-PROBNP, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY BNP/NT-PROBNP, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CK-MB, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CK-MB, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY MYOGLOBIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TROPONIN I/T, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TROPONIN I/T, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY AMPHETAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CANNABINOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CANNABINOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COCAINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COCAINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY OPIATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY OPIATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY MALARIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY MALARIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY FERTILITY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY FERTILITY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY AFP, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY AFP, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CA125, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CA125, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CA19-9, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CA19-9, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PSA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PSA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CASSETTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CASSETTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY STRIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY STRIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HOSPITAL LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY HOSPITAL LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY POINT OF CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY POINT OF CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY MULTIPLEX ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY MULTIPLEX ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SERUM AND PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SERUM AND PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 156. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 157. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 158. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 159. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 160. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 161. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 162. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 163. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 164. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 165. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 166. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 167. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 186. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 187. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PREGNANCY & FERTILITY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TUMOR MARKERS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY CARDIAC MARKERS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY DRUG ABUSE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM COLLOIDAL GOLD IMMUNOCHROMATOGRAPHIC ASSAY POCT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM COLLOIDAL GOLD I

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Colloidal Gold Immunochromatographic Assay POCT market report include:
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson and Company
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • PerkinElmer, Inc.
  • OraSure Technologies, Inc.
  • Meridian Bioscience, Inc.
  • Danaher Corporation

Related Topics

Related Reports

Automatic Colloidal Gold Immunochromatography Analyzer Market - Global Forecast to 2030 - Product Image

Automatic Colloidal Gold Immunochromatography Analyzer Market - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Multi-Channel Colloidal Gold Immunochromatography Analyzer Market - Global Forecast to 2030 - Product Image

Multi-Channel Colloidal Gold Immunochromatography Analyzer Market - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Point-of-Care Testing (POCT) for Substance Abuse Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Point-of-Care Testing (POCT) for Substance Abuse Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Colloidal Gold Diagnostic Test Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Colloidal Gold Diagnostic Test Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Point of Care Testing (POCT) Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Point of Care Testing (POCT) Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 113 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.